Product image of Iblasin (Ibuprofen) supplied by GNH India

Iblasin

Active Ingredient:
Ibuprofen
Origin:
EU

Iblasin (Ibuprofen)

Ibuprofen, the active ingredient in Iblasin, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It relieves mild to moderate pain, reduces fever, and eases inflammation in conditions such as arthritis.
GNH India supplies Iblasin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Italfarmaco S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ibuprofen acts systemically to control pain, fever and inflammation in several common clinical situations.

  • Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal aches and minor injuries.
  • Fever: lowers elevated body temperature associated with infections or other febrile states.
  • Arthritis and other inflammatory conditions: reduces joint swelling, stiffness and improves functional mobility.

How It Works

  • Ibuprofen non‑selectively inhibits cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, decreasing the conversion of arachidonic acid to prostaglandins. The reduced prostaglandin synthesis diminishes peripheral sensitisation of nociceptors, lowers the hypothalamic set‑point for temperature, and limits inflammatory exudate formation, resulting in analgesic, antipyretic and anti‑inflammatory effects.

Side Effects

Adverse reactions may range from mild and transient to serious and life‑threatening.

Common Side Effects

  • Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
  • Headache: mild to moderate intensity.
  • Dizziness or vertigo.
  • Rash or mild skin irritation.
  • Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects

  • Gastrointestinal bleeding, ulceration or perforation.
  • Acute renal failure or worsening of chronic kidney disease.
  • Severe hypersensitivity reactions, including anaphylaxis.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatotoxicity with marked liver enzyme elevation.

Precautions & Warnings

Before using Iblasin, consider the following safety measures.

  • Assess gastrointestinal risk: avoid in patients with active ulcer disease or a history of serious GI bleeding.
  • Evaluate renal function: use caution in individuals with impaired kidney function or dehydration.
  • Monitor cardiovascular status: NSAIDs may increase blood pressure and cardiovascular events.
  • Review concomitant medications: avoid simultaneous use with other NSAIDs, anticoagulants or corticosteroids without medical guidance.
  • Store at room temperature: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Ibuprofen can affect the activity of several other medicines.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): heightened risk of bleeding.
  • Other NSAIDs or aspirin: additive gastrointestinal toxicity.
  • Corticosteroids: increased chance of ulceration.
  • Lithium: ibuprofen may raise serum lithium levels.
  • Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function.
  • Diuretics: may impair renal perfusion.
  • Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk.
  • Beta‑blockers: potential attenuation of blood pressure control.
  • Antidiabetic agents: ibuprofen may affect glucose control.

Frequently Asked Questions

Iblasin contains ibuprofen, an NSAID that is commonly used to relieve mild to moderate pain, reduce fever, and lessen inflammation associated with conditions such as arthritis, musculoskeletal injuries, dental pain, and headaches.

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which lowers the production of prostaglandins. This reduction diminishes pain signalling, lowers body temperature, and curtails the inflammatory response.

The appropriate dose of Iblasin is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and response to therapy. Patients should follow the prescriber’s instructions and the product label.

Safety of ibuprofen in pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester and used only if clearly needed under medical supervision. Breastfeeding mothers should consult a healthcare provider before use.

To place an order, submit an enquiry on the Iblasin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Iblasin (ibuprofen) offers a balance of analgesic, antipyretic and anti‑inflammatory activity with a relatively short half‑life, making it suitable for intermittent dosing. Compared with naproxen, it has a quicker onset but may require more frequent dosing; compared with aspirin, it has less effect on platelet function.

Iblasin should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and excessive heat. Keep the product out of reach of children and do not use it after the expiration date printed on the packaging.

Iblasin is taken orally with a full glass of water. It can be taken with or without food; however, taking it with food or milk may reduce gastrointestinal discomfort. Swallow tablets whole; do not crush or chew unless the formulation specifically allows it.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment, and cardiovascular events like heart attack or stroke, especially with high‑dose or prolonged use. Patients should seek immediate medical attention if they notice signs of bleeding, severe rash, or sudden kidney problems.

Iblasin should be avoided by individuals with a known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or those who are in the third trimester of pregnancy. It is also contraindicated in patients taking certain anticoagulants without medical guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.